Efficacy and Safety of Pembrolizumab in Patients With Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2019.493
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2020
Authors
Publisher
Korean Cancer Association